144 -5 (67) 2024 - Mannobjonov P.B., Khikmatullaeva A.S. - DIAGNOSTIC CRITERIA FOR HUMAN PAPILLOMA VIRUS

DIAGNOSTIC CRITERIA FOR HUMAN PAPILLOMA VIRUS

Mannobjonov P.B. - The Tashkent Medical Academy

Khikmatullaeva A.S. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Abdukadirova M.A. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Akhmedova Sh.Kh. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Abdusattarova V.K. - Department of Sanitary-Epidemiological Welfare and Public Health for the Republic of Karakalpakstan

Resume

Human papillomavirus is one of the most common viruses worldwide that can infect the skin and mucous membranes. Its special significance lies in its high contagiousness and oncogenic potential. Goal of the work. Analysis of literature data on the study of methods for diagnosing human papillomavirus. The article discusses methods for diagnosing human papillomavirus (HPV) and cervical cancer, including the complex method of liquid cytology, methods of treating HPV.

Key words: human papillomavirus, diagnosis.

First page

817

Last page

820

For citation:Mannobjonov P.B., Khikmatullaeva A.S., Abdukadirova M.A., Akhmedova Sh.Kh., Abdusattarova V.K. - DIAGNOSTIC CRITERIA FOR HUMAN PAPILLOMA VIRUS//New Day in Medicine 5(67)2024 817-820 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Milner D.A. Diagnostic Pathology: Infectious Diseases. // Elsevier Health Sciences., 2015., Р.40. ISBN 9780323400374. Archived from the original on 11 September 2017.
  2. de Villiers E.-M., Fauquet C., Broker T. R., Bernard H.-U., zur Hausen H. Phylogenetic tree containing sequences of 118 papillomavirus types. // Virology. 2004; 324: 17-24.
  3. "Human papillomavirus (HPV) and cervical cancer - WHO". //World Health Organization. 22 February 2022. Archived from the original on 22 April 2023.
  4. Ljubojevic S, Skerlev M. HPV-associated diseases. // Clinics in Dermatology. 2014;32(2):227–34. doi:10.1016/j.clindermatol.2013.08.007. PMID 24559558.
  5. Anjum, Fatima; Zohaib, Jamal. Oropharyngeal Squamous Cell Carcinoma. // Definitions, 4 December 2020. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540.
  6. American Society for Colposcopy and Cervical Pathology. 2009 algorithm: use of HPV genotyping to manage HPV HR positive/cytology negative women 30 years and older. http://asccp.org/consensus.shtml. Accessed September 3, 2010.
  7. Solomon D, Papillo J, Davis Davey D Cytopathology Education and Technology Consortium. Statement on HPV DNA test utilization. J Low Genit Tract Dis. 2009;13(3):135-136.
  8. Stoler MH, Castle PE, Solomon D, Schiffman M American Society for Colposcopy and Cervical Pathology. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. //Am J Clin Pathol. 2007;127(3):335-337.
  9. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D 2006 American Society for Colposcopy and Cervical Pathologysponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. //Am J Obstet Gynecol. 2007;197(4):346-355.
  10. Cox J.T., Moriarty A.T., Castle P.E. Commentary on: statement on HPV DNA test utilization. //J Low Genit Tract Dis. 2009;13(3):131-134.
  11. Ikenberg H., Bergeron C., Schmidt D., Griesser H Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. //J Natl Cancer Inst., 2013, Oct., 16; 105(20): 1550-7. doi: 10.1093/jnci/djt235. Epub 2013, Oct. 4.
  12. DiMaio D., Petti L.M.The E5 proteins. //Virology. 2013;445(1-2):99-114. doi: 10.1016/j.virol.2013.05.006.
  13. Phillips S., Garland S.M., Tan J.H., Quinn M.A., Tabrizi S.N. Comparison of the Roche Cobas(®) 4800 HPV assay to Roche Amplicor for detection of high-risk human papillo-mavirus //European Journal of Clinical Microbiology Infectious Diseases. - 2016. - August. -Vol. 35, Issue 8, P. 1305-1307.
  14. Lorincz A.T. Virtues and Weaknesses of DNA Methyla-tion as a Test for Cervical Cancer Prevention //Acta Cyto-logica. 2016;60:501-512.
  15. Agodi A., Barchitta M., Quattrocchi A., Maugeri A., Vin-ciguerra M. DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis //PLOS. -2015. -August.
  16. Вакцины против папилломавирусной инфекции человека: документ по позиции ВОЗ, октябрь 2014 г. //Еженедельный эпидемиологический бюллетень. 2014; 89 (43): 465-92. Vakcinyprotivpa-pillomavirusnoj infekcii cheloveka: dokument po pozicii VOZ, oktyabr' 2014 g. Ezhenedel'nyj epidemiologicheskij byulleten'. 2014; 89 (43): 465-92.

    file

    download